Blog Entry List

The federal COVID-19 Public Health Emergency (PHE) will end May 11, 2023. This bulletin contains important information on the reverification process.

Effective with date of service Jan. 27, 2023, Medicaid and NC Health Choice cover lenacapavir injection

Federal support ending for Resource Utilization Groups III and IV on federally required assessments for patients effective Oct. 1, 2023.

Effective with date of service Jan. 23, 2023, the Medicaid and NC Health Choice programs cover pegfilgrastim-fpgk

Effective with date of service Jan. 20, 2023, the Medicaid and NC Health Choice programs cover fecal microbiota, live - jslm suspension, for rectal use (Rebyota).

Effective with date of service Jan. 30, 2023, the Medicaid and NC Health Choice programs cover bendamustine hydrochloride injection, for intravenous use (Baxter).

Effective with date of service Jan. 27, 2023, the Medicaid and NC Health Choice programs covers ublituximab-xiiy injection, for intravenous use (Briumvi)

In compliance with federal requirements, beneficiary consent is required for all voluntary sterilizations.

Effective April 1, 2023, NC Medicaid covers ambulatory blood pressure monitoring. This helps confirm or exclude suspected hypertension.

Effective immediately, all providers must use the Electronic Visit Verification vendor of their choice for every home health visit.

Clarifies requirements related to Research Based-Behavioral Health Treatment and Specialized Consultative Services and New Taxonomy

CCP 1A-39 has been updated to reflect changes in 1905(a) of the Social Security Act

Providers are required to make adequate provision for return of any money incorrectly collected 

Physician’s signature on the CMS 485 Plan of Care form

Provider reverification, Tailored Plans start date Oct. 1, upcoming key milestones, playbook updates, billing requirement modifications and more.